- Home
- CGEM vs DJCO Comparison
CGEM vs DJCO Comparison
Compare CGEM & DJCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- DJCO
- Stock Information
- Founded
- CGEM 2016
- DJCO 1987
- Country
- CGEM United States
- DJCO United States
- Employees
- CGEM N/A
- DJCO N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- DJCO Newspapers/Magazines
- Sector
- CGEM Health Care
- DJCO Consumer Discretionary
- Exchange
- CGEM Nasdaq
- DJCO Nasdaq
- Market Cap
- CGEM 530.0M
- DJCO 569.1M
- IPO Year
- CGEM 2021
- DJCO N/A
- Fundamental
- Price
- CGEM $8.18
- DJCO $409.50
- Analyst Decision
- CGEM Strong Buy
- DJCO
- Analyst Count
- CGEM 6
- DJCO 0
- Target Price
- CGEM $28.17
- DJCO N/A
- AVG Volume (30 Days)
- CGEM 331.3K
- DJCO 57.0K
- Earning Date
- CGEM 08-07-2025
- DJCO 08-13-2025
- Dividend Yield
- CGEM N/A
- DJCO N/A
- EPS Growth
- CGEM N/A
- DJCO 375.38
- EPS
- CGEM N/A
- DJCO 76.72
- Revenue
- CGEM N/A
- DJCO $73,247,000.00
- Revenue This Year
- CGEM N/A
- DJCO N/A
- Revenue Next Year
- CGEM N/A
- DJCO N/A
- P/E Ratio
- CGEM N/A
- DJCO $5.34
- Revenue Growth
- CGEM N/A
- DJCO 1.99
- 52 Week Low
- CGEM $6.85
- DJCO $359.34
- 52 Week High
- CGEM $20.96
- DJCO $602.00
- Technical
- Relative Strength Index (RSI)
- CGEM 54.88
- DJCO 53.16
- Support Level
- CGEM $7.42
- DJCO $396.16
- Resistance Level
- CGEM $8.70
- DJCO $410.37
- Average True Range (ATR)
- CGEM 0.38
- DJCO 10.96
- MACD
- CGEM 0.09
- DJCO 0.83
- Stochastic Oscillator
- CGEM 63.12
- DJCO 76.37
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.